A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers

Abstract

The lack of specific symptoms at early tumor stages, together with a high biological aggressiveness of the tumor contribute to the high mortality rate for pancreatic cancer (PC), which has a five year survival rate of less than 5%. Improved screening for earlier diagnosis, through the detection of diagnostic and prognostic biomarkers provides the best hope of increasing the rate of curatively resectable carcinomas. Though many serum markers have been reported to be elevated in patients with PC, so far, most of these markers have not been implemented into clinical routine due to low sensitivity or specificity. In this study, we have identified genes that are significantly upregulated in PC, through a meta-analysis of large number of microarray datasets. We demonstrate that the biological functions ascribed to these genes are clearly associated with PC and metastasis, and that that these genes exhibit a strong link to pathways involved with inflammation and the immune response. This investigation has yielded new targets for cancer genes, and potential biomarkers for pancreatic cancer. The candidate list of cancer genes includes protein kinase genes, new members of gene families currently associated with PC, as well as genes not previously linked to PC. In this study, we are also able to move towards developing a signature for hypomethylated genes, which could be useful for early detection of PC. We also show that the significantly upregulated 800+ genes in our analysis can serve as an enriched pool for tissue and serum protein biomarkers in pancreatic cancer.

Analysis of K-Ras Interactions by Biotin Ligase Tagging

“…One probable reason AHNAK and its sister protein AHNAK2 were identified in our study is that they both present large biotinylation target sizes. However, both are plasma membrane-associated, and have been observed to be up-regulated in certain cancers, including pancreatic cancers (77).…”

Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer’s disease

“…The basic theory of meta-analysis of microarray study was described initially by Choi et al 49 , and has subsequently been modified and widely applied 7 50 51 52 . Here we briefly provide the application formulas proposed by Marot et al 52 , which involve an inverse variance-weighted effect size meta-analysis method based on moderated t- statistics calculated by the limma R package 48 .…”

Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma—A meta-analysis approach

“…Advancement in the technologies and high throughput global profiling have led to the identification of a repertoire of candidate markers that can qualify as molecular prognosticators [17][18][19][20]. These markers can be predictive (to evaluate the likelihood of benefit from a specific clinical intervention) or prognostic (to evaluate the patient's overall outcome).…”